510(k) K073014

INFINITI 2C9 & VKORC1 MULTIPLEX ASSAY FOR WARFARIN by Autogenomics, Incorporated — Product Code ODW

K073014 is an FDA 510(k) premarket notification submitted by Autogenomics, Incorporated for the device "INFINITI 2C9 & VKORC1 MULTIPLEX ASSAY FOR WARFARIN". The FDA issued a decision of Substantially Equivalent on Jan 23, 2008. The device falls under product code ODW (Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System), a Class II device regulated under 21 CFR 862.3360. Autogenomics, Incorporated has 1 other 510(k) clearance on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 23, 2008
Date Received
Oct 25, 2007
Clearance Type
Abbreviated
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Device Class
Class II
Regulation Number
862.3360
Review Panel
TX
Submission Type
510(k)

An in vitro diagnostic assay for use in genotyping Cytochrome P450 2C9 (CYP450 2C9) alleles. Information about the CYP2C9 genotype may be used as an aid to clinicians in determining therapeutic strategy for medications that are metabolized by the CYP2C9 gene product.

Need the full FDA record for Autogenomics, Incorporated? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K073014. Report a data issue: hello@regdatalab.com.